Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall | Zendy

Anna Missiou | Zendy; Natascha Köstlin | Zendy; Nerea Varo | Zendy; Philipp Rudolf | Zendy; Peter Aichele | Zendy; Sandra Ernst | Zendy; Christian Münkel | Zendy; Carina Walter | Zendy; Peter Stachon | Zendy; Benjamin Sommer | Zendy; Dietmar Pfeifer | Zendy; Katja Zirlik | Zendy; Lindsey A. MacFarlane | Zendy; Dennis Wolf | Zendy; Erdyni N. Tsitsikov | Zendy; Christoph Bode | Zendy; Peter Libby | Zendy; Andreas Zirlik | Zendy

Open Access

Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall

Author(s) -

Anna Missiou,

Natascha Köstlin,

Nerea Varo,

Philipp Rudolf,

Peter Aichele,

Sandra Ernst,

Christian Münkel,

Carina Walter,

Peter Stachon,

Benjamin Sommer,

Dietmar Pfeifer,

Katja Zirlik,

Lindsey A. MacFarlane,

Dennis Wolf,

Erdyni N. Tsitsikov,

Christoph Bode,

Peter Libby,

Andreas Zirlik

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.895037

Subject(s) - tumor necrosis factor alpha , medicine , tumor necrosis factor receptor 1 , cell adhesion molecule , monocyte , endothelium , inflammation , intercellular adhesion molecule , intercellular adhesion molecule 1 , immunology , cancer research , cell adhesion , endocrinology , biology , cell , genetics , tumor necrosis factor receptor

Members of the tumor necrosis factor superfamily, such as tumor necrosis factor-alpha, potently promote atherogenesis in mice and humans. Tumor necrosis factor receptor-associated factors (TRAFs) are cytoplasmic adaptor proteins for this group of cytokines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research